1
EXHIBIT 10.14
SIGNAL PHARMACEUTICALS, INC.
AMENDMENT TO AMENDED AND RESTATED
INVESTORS' RIGHTS AGREEMENT
THIS AMENDMENT TO AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT (the
"Amendment") is entered into as of November 25, 1997, by and among SIGNAL
PHARMACEUTICALS, INC., a California corporation (the "Company"), and the
undersigned parties (the "Investors") to that certain Amended and Restated
Investors' Rights Agreement dated as of September 9, 1997 (the "Agreement") in
connection with that certain Series F Preferred Stock Purchase Agreement of even
date herewith (the "Stock Purchase Agreement") providing for the issuance and
sale of 2,722,513 shares of Series F Preferred Stock to Ares-Serono S.A. (the
"Financing"). Capitalized terms contained herein shall have the meanings set
forth in the Agreement.
WHEREAS, the Company and the Investors desire to amend the Agreement as
set forth below; and
WHEREAS, the execution of this Amendment by the parties is a condition
to the Financing as set forth in Section 5.7 of the Stock Purchase Agreement.
NOW, THEREFORE, in consideration of the foregoing premises and the
mutual promises set forth below, and for other good and valuable consideration,
the receipt of which is hereby acknowledged, the parties to this Amendment agree
as follows:
1. The definition of "Investor Registrable Securities" set forth in
Section 1.1(d) of the Agreement is hereby amended to read in its entirety as
follows:
The term "Investor Registrable Securities" means (1) the Common
Stock issuable or issued upon conversion of any Series A Preferred
Stock, (2) the Common Stock issuable or issued upon conversion of any
Series B Preferred Stock, (3) the Common Stock issuable or issued upon
conversion of any Series C Preferred Stock, (4) the Common Stock
issuable or issued upon conversion of any Series E Preferred Stock, (5)
the Common Stock issuable or issued upon conversion of any Series F
Preferred Stock, and (6) any Common Stock of the Company issued as (or
issuable upon the conversion or exercise of any warrant, right or other
security which is issued as) a dividend or other distribution with
respect to, or in exchange for or in replacement of, such Series A
Preferred Stock, Series B Preferred Stock, Series C Preferred Stock,
Series E Preferred Stock, Series F Preferred Stock or Common Stock
issuable or issued upon conversion
1.
2
thereof, excluding in all cases, however, any Investor Registrable
Securities sold by a person in a transaction in which his rights under
this Section 1 are not assigned.
2. The first paragraph of Section 2.3 of the Agreement is hereby amended
to read in its entirety as follows:
2.3 RIGHT OF FIRST OFFER. Subject to the terms and conditions
specified in this paragraph 2.3, the Company hereby grants to each Major
Investor (as hereinafter defined) a right of first offer with respect to
future sales by the Company of its Shares (as hereinafter defined). For
purposes of this Section 2.3, a Major Investor shall mean any Investor
who holds not less than 100,000 shares of Series A, Series B, Series C,
Series E or Series F Preferred Stock in the aggregate. For purposes of
this Section 2.3, Investor includes any general partners and affiliates
of an Investor. An Investor shall be entitled to apportion the right of
first offer hereby granted it among itself and its partners and
affiliates in such proportions as it deems appropriate.
3. Section 2.3(b) of the Agreement is hereby amended to read in its
entirety as follows:
(b) By written notification received by the Company, within 20
calendar days after giving of the Notice, the Major Investor may elect
to purchase or obtain, at the price and on the terms specified in the
Notice, up to that portion of such Shares which equals the proportion
that the number of shares of common stock issued and held, or issuable
upon conversion of the Series A, Series B, Series C, Series E and Series
F Preferred Stock then held, by such Major Investor bears to the total
number of shares of common stock of the Company then outstanding
(assuming full conversion and exercise of all convertible or exercisable
securities) (the "Pro Rata Share"). The Company shall promptly, in
writing, inform each Major Investor which purchases all the shares
available to it ("Fully-Exercising Investor") of any other Major
Investor's failure to do likewise. During the ten-day period commencing
after such information is given, each Fully-Exercising Investor shall be
entitled to obtain that portion of the Shares for which Major Investors
were entitled to subscribe but which were not subscribed for by the
Major Investors which is equal to the proportion that the number of
shares of common stock issued and held, or issuable upon conversion of
Series A, Series B, Series C, Series E and Series F Preferred Stock then
held, by such Fully-Exercising Investor bears to the total number of
shares of common stock issued and held, or issuable upon conversion of
the Series A, Series B, Series C, Series E and Series F Preferred Stock
then held, by all Fully-Exercising Investors who wish to purchase some
of the unsubscribed shares.
2.
3
4. Section 3.1 of the Agreement is hereby amended to read in its
entirety as follows:
3.1 SUCCESSORS AND ASSIGNS. Except as otherwise provided herein,
the terms and conditions of this Agreement shall inure to the benefit of
and be binding upon the respective successors and assigns of the parties
(including transferees of any shares of Series A Preferred Stock, Series
B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock,
Series E Preferred Stock, Series F Preferred Stock or any Common Stock
issued upon conversion thereof). Nothing in this Agreement, express or
implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies,
obligations, or liabilities under or by reason of this Agreement, except
as expressly provided in this Agreement.
5. This Amendment shall be deemed an amendment to the Agreement and
shall become effective when executed by the Company and the holders of at least
a majority of the outstanding shares of Registrable Securities as provided for
under Section 3.7 of the Agreement. Except as expressly amended pursuant to this
Amendment, the Agreement shall continue in full force and effect.
6. This Amendment shall be governed by the laws of the State of
California as applicable to contracts entered into and performed entirely within
the State of California by residents of California.
7. This Amendment may be executed in counterparts, each of which shall
be enforceable against the party actually executing such counterpart, and which
together shall constitute one instrument.
[The remainder of this page is intentionally left blank]
3.
4
IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.
COMPANY:
SIGNAL PHARMACEUTICALS, INC.
By:
------------------------------------
Xxxx X. Xxxxx, President
and Chief Executive Officer
INVESTORS:
ARES-SERONO S.A.
By:
-----------------------------------
Its:
-----------------------------------
BIOCENTIVE
By:
-----------------------------------
Its:
-----------------------------------
FINSBURY WORLDWIDE PHARMACEUTICAL
TRUST, PLC
By:
-----------------------------------
Its:
-----------------------------------
5
LOMBARD ODIER IMMUNOLOGY FUND
By:
-----------------------------------
Its:
-----------------------------------
NEUROSCIENCE PARTNERS LIMITED
PARTNERSHIP
By:
-----------------------------------
Its:
-----------------------------------
NEW YORK LIFE INSURANCE COMPANY
By:
-----------------------------------
Its:
-----------------------------------
PHARMA/WHEALTH
By:
-----------------------------------
Its:
-----------------------------------
THE HEALTH CARE AND BIOTECHNOLOGY
VENTURE FUND
By:
-----------------------------------
Its:
-----------------------------------
6
BAYVIEW INVESTORS LTD.
By:
-----------------------------------
Its:
-----------------------------------
VENROCK ASSOCIATES
By:
-----------------------------------
Its:
-----------------------------------
VENROCK ASSOCIATES II, L.P.
By:
-----------------------------------
Its:
-----------------------------------
XXXXXXX XXXXXXX XXXXXXXX & XXXXX VI
By:
-----------------------------------
Its:
-----------------------------------
ACCEL INVESTORS `93 L.P.
By:
-----------------------------------
Its:
-----------------------------------
ACCEL IV L.P.
By:
-----------------------------------
Its:
-----------------------------------
Signature Page to Amendment to Amended and Restated Investors' Rights Agreement
7
ACCEL JAPAN L.P.
By:
-----------------------------------
Its:
-----------------------------------
ACCEL KEIRETSU L.P.
By:
-----------------------------------
Its:
-----------------------------------
XXXXXXX X. XXXXXXXXX PARTNERS
By:
-----------------------------------
Its:
-----------------------------------
PROSPER PARTNERS
By:
-----------------------------------
Its:
-----------------------------------
INTERWEST INVESTORS V
By:
-----------------------------------
Its:
-----------------------------------
INTERWEST PARTNERS V
By:
-----------------------------------
Its:
-----------------------------------
Signature Page to Amendment to Amended and Restated Investors' Rights Agreement
8
OXFORD BIOSCIENCE PARTNERS (ADJUNCT)
L.P.
By:
-----------------------------------
Its:
-----------------------------------
OXFORD BIOSCIENCE PARTNERS (BERMUDA)
L.P.
By:
-----------------------------------
Its:
-----------------------------------
OXFORD BIOSCIENCE PARTNERS L.P.
By:
-----------------------------------
Its:
-----------------------------------
SECOND VENTURES II, L.P.
By:
-----------------------------------
Its:
-----------------------------------
U.S. VENTURES PARTNERS IV, L.P.
By:
-----------------------------------
Its:
-----------------------------------
USVP ENTREPRENEUR PARTNERS II, L.P.
By:
-----------------------------------
Its:
-----------------------------------
Signature Page to Amendment to Amended and Restated Investors' Rights Agreement
9
XXXXX X. XXXXXX, XX. SEPARATE PROPERTY
TRUST, DATED DECEMBER 15, 1995
By:
-----------------------------------
Its:
-----------------------------------
VERTICAL FUND ASSOCIATES, L.P.
By:
-----------------------------------
Its:
-----------------------------------
XXXXXX BROTHERS
By:
-----------------------------------
Its:
-----------------------------------
XXXXXXXXX & XXXXX
By:
-----------------------------------
Its:
-----------------------------------
XXXXXXXXX, XXXXXXXX & COMPANY
By:
-----------------------------------
Its:
-----------------------------------
Signature Page to Amendment to Amended and Restated Investors' Rights Agreement
10
XXXXX X. XXXXXX FAMILY TRUST,
DATED 8/25/86
By:
-----------------------------------
Its:
-----------------------------------
XXXXXXXXX X. XXXXXX
----------------------------------------
TANABE SEIYAKU CO., LTD.
By:
-----------------------------------
Its:
-----------------------------------
VERTICAL MEDICAL PARTNERS L.P.
By:
-----------------------------------
Its:
-----------------------------------
Signature Page to Amendment to Amended and Restated Investors' Rights Agreement
